{
    "matches": [
        {
            "Extracted_claim": {
                "subject": {
                    "Study": "An X et al",
                    "Year": "2010",
                    "n": "89",
                    "Number of patients with NLR >5": "16 (17.9)",
                    "Overall survival (NLR >5 vs. \u22645)": "2.4 versus 7.7",
                    "Hazard ratio": "HR = 4.49, P = 0.013"
                },
                "measures": "[Study, Citation, Year, n, Number of patients with NLR >5, Overall survival (NLR >5 vs. \u22645), Hazard ratio]",
                "outcomes": "[Prognostic factor, Independent, OS, Palliative chemotherapy, APC patients]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "Study": "An X et al.",
                    "Year": "2010",
                    "number of patients": "89",
                    "Number of patientis with NLR > 5 (%)": "16 (17.9)",
                    "Overall survival (NLR >5 vs \u22645) (months)": "2.4 versus 7.7",
                    "NLR \u22645": "1"
                },
                "measures": "[Hazard Ratio, P-Value]",
                "outcomes": "[4.49, 0.013]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study": "Wang DS et al",
                    "Year": "2012",
                    "n": "86",
                    "Number of patients with NLR >5": "12 (13.9)",
                    "Overall survival (NLR >5 vs. \u22645)": "5.8 versus 10.2",
                    "Hazard ratio": "NA"
                },
                "measures": "[Study, Citation, Year, n, Number of patients with NLR >5, Overall survival (NLR >5 vs. \u22645), Hazard ratio]",
                "outcomes": "[Prognostic factor, Independent, OS, Palliative chemotherapy, APC patients]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "Study": "Wang DS et al.",
                    "Year": "2012",
                    "number of patients": "86",
                    "Number of patientis with NLR > 5 (%)": "12 (13.9)",
                    "Overall survival (NLR >5 vs \u22645) (months)": "5.8 versus 10.2",
                    "NLR \u22645": "1"
                },
                "measures": "[]",
                "outcomes": "[]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study": "Stotz M et al",
                    "Year": "2013",
                    "n": "261",
                    "Number of patients with NLR >5": "79 (30.3)",
                    "Hazard ratio": "HR = 2.53, P < 0.01"
                },
                "measures": "[Study, Citation, Year, n, Number of patients with NLR >5, Hazard ratio]",
                "outcomes": "[Prognostic factor, Independent, OS, Palliative chemotherapy, APC patients]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "Study": "Stotz M et al.",
                    "Year": "2013",
                    "number of patients": "261",
                    "number of patients who received chemotherapy": "179",
                    "number of patients who did not received chemotherapy": "82",
                    "Number of patientis with NLR > 5 (%)": "79 (30.3)",
                    "Overall survival (NLR >5 vs \u22645) (months)": "NA",
                    "NLR \u22645": "1"
                },
                "measures": "[Hazard Ratio, P-Value]",
                "outcomes": "[2.53, <0.01]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study": "Stotz M et al",
                    "Year": "2013",
                    "n": "261",
                    "Number of patients with NLR >5": "79 (30.3)",
                    "Hazard ratio": "HR = 2.53, P < 0.01"
                },
                "measures": "[Study, Citation, Year, n, Number of patients with NLR >5, Hazard ratio]",
                "outcomes": "[Prognostic factor, Independent, OS, Palliative chemotherapy, APC patients]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "Study": "Our study",
                    "Year": "2013",
                    "number of patients": "253",
                    "Number of patientis with NLR > 5 (%)": "40 (15.8)",
                    "Overall survival (NLR >5 vs \u22645) (months)": "6.0 versus 12.8",
                    "NLR \u22645": "1"
                },
                "measures": "[Hazard Ratio, P-Value]",
                "outcomes": "[1.95, <0.01]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study": "Our study",
                    "Year": "2013",
                    "n": "253",
                    "Number of patients with NLR >5": "40 (15.8)",
                    "Overall survival (NLR >5 vs. \u22645)": "6.0 versus 12.8",
                    "Hazard ratio": "HR = 1.95, P < 0.01"
                },
                "measures": "[Study, Citation, Year, n, Number of patients with NLR >5, Overall survival (NLR >5 vs. \u22645), Hazard ratio]",
                "outcomes": "[Prognostic factor, Independent, OS, Palliative chemotherapy, APC patients]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "Study": "Stotz M et al.",
                    "Year": "2013",
                    "number of patients": "261",
                    "number of patients who received chemotherapy": "179",
                    "number of patients who did not received chemotherapy": "82",
                    "Number of patientis with NLR > 5 (%)": "79 (30.3)",
                    "Overall survival (NLR >5 vs \u22645) (months)": "NA",
                    "NLR \u22645": "1"
                },
                "measures": "[Hazard Ratio, P-Value]",
                "outcomes": "[2.53, <0.01]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Study": "Our study",
                    "Year": "2013",
                    "n": "253",
                    "Number of patients with NLR >5": "40 (15.8)",
                    "Overall survival (NLR >5 vs. \u22645)": "6.0 versus 12.8",
                    "Hazard ratio": "HR = 1.95, P < 0.01"
                },
                "measures": "[Study, Citation, Year, n, Number of patients with NLR >5, Overall survival (NLR >5 vs. \u22645), Hazard ratio]",
                "outcomes": "[Prognostic factor, Independent, OS, Palliative chemotherapy, APC patients]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "Study": "Our study",
                    "Year": "2013",
                    "number of patients": "253",
                    "Number of patientis with NLR > 5 (%)": "40 (15.8)",
                    "Overall survival (NLR >5 vs \u22645) (months)": "6.0 versus 12.8",
                    "NLR \u22645": "1"
                },
                "measures": "[Hazard Ratio, P-Value]",
                "outcomes": "[1.95, <0.01]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Caption": "Summary of published studies reporting the association between NLR and the prognosis of APC patients receiving chemotherapy"
                },
                "measures": "[Context, Published studies, APC patients, Palliative chemotherapy]",
                "outcomes": ""
            },
            "Ground_truth_claim": {
                "subject": {
                    "Study": "Stotz M et al.",
                    "Year": "2013",
                    "number of patients": "261",
                    "number of patients who received chemotherapy": "179",
                    "number of patients who did not received chemotherapy": "82",
                    "Number of patientis with NLR > 5 (%)": "79 (30.3)",
                    "Overall survival (NLR >5 vs \u22645) (months)": "NA",
                    "NLR \u22645": "1"
                },
                "measures": "[Hazard Ratio, P-Value]",
                "outcomes": "[2.53, <0.01]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citations": "The present results are in line with those of previous studies 16,17 reporting that elevated NLR was an independent prognostic factor for OS in APC patients receiving palliative chemotherapy"
                },
                "measures": "[Context, Previous studies, APC patients, Palliative chemotherapy]",
                "outcomes": ""
            },
            "Ground_truth_claim": {
                "subject": {
                    "Study": "Stotz M et al.",
                    "Year": "2013",
                    "number of patients": "261",
                    "number of patients who received chemotherapy": "179",
                    "number of patients who did not received chemotherapy": "82",
                    "Number of patientis with NLR > 5 (%)": "79 (30.3)",
                    "Overall survival (NLR >5 vs \u22645) (months)": "NA",
                    "NLR \u22645": "1"
                },
                "measures": "[Hazard Ratio, P-Value]",
                "outcomes": "[2.53, <0.01]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "Citations": "The proportion of patients with a pretreatment NLR of >5 in existing research are comparable across studies"
                },
                "measures": "[Context, Existing research, APC patients]",
                "outcomes": ""
            },
            "Ground_truth_claim": {
                "subject": {
                    "Study": "Stotz M et al.",
                    "Year": "2013",
                    "number of patients": "261",
                    "number of patients who received chemotherapy": "179",
                    "number of patients who did not received chemotherapy": "82",
                    "Number of patientis with NLR > 5 (%)": "79 (30.3)",
                    "Overall survival (NLR >5 vs \u22645) (months)": "NA",
                    "NLR \u22645": "1"
                },
                "measures": "[Hazard Ratio, P-Value]",
                "outcomes": "[2.53, <0.01]"
            },
            "match": "no"
        }
    ],
    "total_extracted_claims": 7,
    "total_ground_truth_claims": 4,
    "number_of_matches": 3
}